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Ov20 is a structurally novel 20-kDa retinol binding protein secreted by Onchocerca volvulus. Immunological
and biological investigation of this protein has been hampered by the inability to maintain O. volvulus in a
laboratory setting. In an effort to find a system more amenable to laboratory investigation, we have cloned,
sequenced, and expressed cDNA encoding homologues of Ov20 from two closely related filarial species, Brugia
malayi (Bm20) and Acanthocheilonema viteae (Av20). Sequence comparisons have highlighted differences in
glycosylation of the homologues. We present here an analysis of mouse immune responses to Ov20, Bm20, and
Av20. The results suggest a strong genetic restriction in response to native Bm20 that is overcome when
recombinant, nonnative material is used. Reactivity of human filarial sera to the three recombinant proteins
confirmed previous specificity studies with Ov20 but highlighted important differences in the reactivity pat-
terns of the O. volvulus and B. malayi homologues that may be due to differences in glycosylation patterns. Ov20
is a dominant antigen in infected individuals, while Bm20 is not. The availability of the B. malayi homologue
enabled us to use defined murine reagents and inbred strains for genetic analysis of responsiveness in a way
that is not possible for Ov20. However, the close sequence similarity between Ov20 and Av20 suggests that the
A. viteae model may be more suited to the investigation of the biological functions of Ov20.
Infection of humans by parasitic filariae leads to a spectrum
of clinical manifestations ranging from a remarkable absence
of responsiveness to severe immunopathological conditions
like elephantiasis and irreversible blindness (17, 21, 22). The
final outcome of an infection, whether it be protective immu-
nity, tolerance, or disease development, is largely dependent
on the way in which the host immune system recognizes and
responds to these multicellular organisms (16, 21, 22). To un-
derstand and unravel these complex immunological interac-
tions between parasites and their mammalian hosts, it is crucial
to look at specific responses to individual antigens.
Ov20 is an immunodominant glycoprotein antigen of On-
chocerca volvulus, the causative agent of river blindness in
humans. A major part of the clone (OvMBP20/11) has shown
a high degree of specificity to onchocerciasis sera, with sera
from related nematodes failing to react despite homologues of
this protein being present in the other species (3, 4). The
protein has been incorporated in a serodiagnostic tool to an-
alyze human immune responses to Onchocerca infection (4, 5,
24). Fluorescence-based ligand binding assays show the protein
to contain a high-affinity ligand binding site for retinol; algo-
rithms which predict secondary structure indicate a predomi-
nance of alpha helices, with no evidence of the beta structures
seen in retinol binding proteins characterized so far (15). Ov20,
thus represents a new class of helix-rich retinol binding protein
of unknown function and appears to be confined to nematodes
(15, 31).
The full-length cDNA corresponding to Ov20 has been iso-
lated, and extensive database searches failed to detect similar-
ity to proteins of known function; however, its antigenic and
sequence conservation in a wide range of nematodes suggests
an important biological role (31). The only other family of
retinol binding proteins of similar size and helicity are individ-
ual units of the polyprotein allergens of nematodes such as
ABA-1 of Ascaris suum and gp15/400 of Brugia malayi (13, 14).
Retinoids have been implicated in a variety of biological
functions in vertebrate and nonvertebrate systems (6, 7, 11, 12,
29). O. volvulus is known to sequester retinol to a concentra-
tion eight times in excess of the surrounding host tissue (30).
Initial clinical manifestations of onchocercal eye damage in-
clude night blindness, a symptom consistent with retinol defi-
ciency (25). Although the in vivo function of Ov20 with respect
to both the worm and the host is yet to be established, retinol
segregation, initial symptoms compatible with retinol defi-
ciency, and secretion of a unique immunodominant retinol
binding protein suggest that this molecule is worthy of further
investigation. The lack of an animal model for onchocerciasis
has hampered further characterization of Ov20, creating a
need for homologues of this molecule to be cloned and ex-
pressed in parasite systems where animal work is possible. We
selected the human filarial parasite B. malayi, the causative
agent of lymphatic filariasis, and the rodent filarial parasite
Acanthocheilonema viteae, which because of its close phyloge-
netic relationship to O. volvulus has been considered a model
for onchocerciasis.
The objectives of this study were twofold: first, to identify by
cloning of the homologous proteins a reliable candidate for
modelling the immune response to Ov20 and second, to ana-
lyze the immune reactivity of infected mice and humans to the
different recombinants to elucidate differences in protein
structure that may influence immune responsiveness. Here we
report on the isolation and expression of cDNA encoding the
homologues of Ov20 in B. malayi (Bm20) and A. viteae (Av20).
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Sequence comparisons highlighted differences in the pattern of
glycosylation in the homologues, allowing evaluation of the
role of glycosylation in antigen recognition. Further, the avail-
ability of sera from inbred mice inoculated with B. malayi
allowed a genetic analysis of responsiveness that would not be
possible for Ov20.
MATERIALS AND METHODS
Cloning of Av20. DNA encoding the A. viteae homologue was amplified from
an adult cDNA library with PCR and cloned into pET-15b (Novagen, Madison,
Wis.), with an intermediate cloning into pUC18. The oligonucleotide primers for
Ov20 used for the PCR (Ov20HTF [59 CTC CAT ATG GCA AAT GTT GTT
CCG TTT TC 39] and Ov20HTR [59 CTC GGA TCC TTA ATG TTT TCC GGC
ACC 39]) were designed to generate a protein starting from the predicted
cleavage site for the signal peptide, Asn17, of the Ov20 sequence. The inserts
which were originally cloned into SmaI-digested pUC18 by blunt-end ligation
and transformed into the Escherichia coli DH5a were subcloned into pET-15b by
using the NdeI and BamHI sites.
Cloning of Bm20. Oligonucleotides derived from the Ov20 sequence were used
to find the Brugia homologues. To obtain the full-length Brugia sequence, the
upstream primer was used with an oligo (dT) primer, and the downstream primer
was used with a primer for the spliced leader sequence found on most B. malayi
transcripts. Template DNA was derived from Brugia adult or microfilarial cDNA
amplified with the spliced leader and oligo (dT) primers courtesy of Bill Gregory.
Sequences were also obtained from conventional microfilarial and adult cDNA
libraries provided by Steve Williams, Smith College. Oligonucleotides included
XBA-1, NdeI, PstI, and BamHI sites for ease of cloning. 59 oligonucleotides used
were Ov20XN (TTTCTAGAACCATGGCAAATGTTGTTCCTG), Ov20PB
(CCGGATCCTGCAGTCTCTAATTCTTTTGCAGAA), SL1-f3 (GCTCTAG
AGCGGCCGCGGGGTTTAATTACCCAAGTTGGAG), and dGdT (AAT
TGGATCCCCCGGGT). Positive PCR products were cloned into pBluescript
(Promega, Madison, Wis.) and sequenced. For expression, a new upstream oligo-
nucleotide that corresponded to the newly determined Brugia sequence, BM20XN
(GTTTCTAGAACCATGGCAAATGTTATTCCTTTCT), was synthesized.
This oligonucleotide was used with dGdT, and the amplified product was cloned
into pET-15b (Novagen). The NcoI site of pET-15b, which allowed expression of
the sequence without the histidine tag, was used. The expressed sequence starts
with Met15, two amino acids before the predicted peptide cleavage site.
Expression and purification of Bm20, Av20, and Ov20. Bm20 and Av20 were
expressed in the E. coli BLD21(DE3) with 1 mM isopropyl 1-b-D-thiogalacto-
pyranoside (Sigma, Dorset, United Kingdom) induction, and host cells were
lysed by lysozyme treatment and sonication as described by the manufacturer
(Novagen). Bm20 was purified by fast protein liquid chromatography using an
anion-exchange column (Mono Q HR 5/5; Pharmacia, Uppsala, Sweden). Puri-
fication initially used an increasing gradient of sodium chloride, and further
purification involved the use of step gradients. Expression of Av20 in the pET-
15b expression vector utilized the polyhistidine domain to facilitate purification.
Studies on Ov20 have shown that the biochemical properties of the Ov20 bearing
the His6 affinity tag and protein in which the tag had been removed with throm-
bin were indistinguishable (15). In the interest of reducing manipulation, there-
fore, all assays reported here were carried out with the His6 tag fusion protein.
Purification of Av20 was by affinity column chromatography as instructed by the
manufacturer (Novagen) for high yield. The purity of the recombinants was
verified on 15% polyacrylamide gels. Previously prepared Ov20 was available in
E. coli BLD21(DE3). Expression and purification have been previously described
(15).
Sequencing. Template plasmid DNA for sequencing was prepared according
to the protocol for the Wizard Miniprep kit (Promega) or Plasmid Mini-kit
(Qiagen). Sequencing was performed with an ABI PRISM terminator cycle
sequencing ready reaction kit (Perkin-Elmer) using the vector-specific forward
and reverse primers, and analyzed on an ABI PRISM 377 (Perkin-Elmer).
Sequences and chromatograms were compared and verified by using SeqEd
version 1.0.3; translation, reading frame, and predictions of secondary structure,
molecular weight, and pI were performed with MacVector version 4.1.4.
Parasite extracts. Live adult worms were obtained from the peritoneal cavities
of B malayi-infected jirds (Meriones unguiculatus). B. malayi antigen was prepared
by homogenization of adult worms in phosphate-buffered saline on ice followed
by centrifugation at 10,000 3 g for 20 min. The supernatant was passed through
a 0.5-mm-pore-size filter, and the protein concentration was determined by Brad-
ford analysis.
Immunization and implantation sera. Immunization sera were obtained from
BALB/c (H-2D, CBA (H-2K), BALB.k (H-2K), and B10.D2 (H-2D) mice immu-
nized with Bm20 or whole Brugia malayi antigen in Freund’s complete adjuvant
(Sigma Immuno-chemicals). Implantation sera were from C57BL/6, BALB/c,
CBA, and BALB.k mice implanted intraperitoneally with adult B. malayi. Sera
were taken 3 to 4 weeks after implantation with six viable adult females and three
to six viable adult males. Antiserum to recombinant Ov20 and Ov20/11 was
generated by immunization of mice with the recombinant molecules produced in
E. coli (31). Ov20/11 is the fragment encoded by the major part of the Ov20
cDNA clone, which was selected as a serodiagnostic tool on the basis of its
specificity.
Human sera. Onchocerciasis sera (35 samples) were obtained from confirmed
microfilaria-positive patients from an area with a high transmission of onchocer-
ciasis, the Sanega river basin in Cameroon. Wuchereria bancrofti-positive sera
were obtained from microfilaria-positive individuals living in the Philippines or
Sri Lanka (22 samples). The B. malayi sera (16 samples) were obtained from
Sulawesi, Indonesia. The control sera (8 to 10 samples) were obtained from
individuals from areas in Ecuador and Sudan where onchoceriasis is not en-
demic.
ELISAs. The reactivity of the expressed proteins to mice sera was assessed by
an enzyme-linked immunosorbent assay (ELISA) at an antigen concentration of
1 mg/ml and a serum dilution of 1/100. Antibody binding was revealed by using
an anti-mouse peroxidase conjugate (Dakinopatts, Copenhagen, Denmark) at a
dilution of 1/1,000 and tetramethylbenzidine (microwell) as substrate. The hu-
man serum ELISAs had an anti-human immunoglobulin G (clone MO 6014;
Oxoid, New York, N.Y.) monoclonal antibody as the secondary antibody and an
anti-mouse peroxidase conjugate as the tertiary antibody. The plates were read
15 min after addition of the substrate on an ELISA reader at an optical density
of 405 nm.
Statistical analysis. Differences in mean for selected data were analyzed for
significance by using a paired or unpaired Student t test, as appropriate. Degrees
of freedom were calculated accordingly. P , 0.05 was taken as significant.
Nucleotide sequence accession number. The fully confirmed Bm20 sequence
was submitted to GenBank and given accession no. U69169.
RESULTS
Sequence comparison. Homologues of Ov20 were cloned
from B. malayi and A. viteae and sequenced for comparison
with the Onchocerca molecule. Expression and purification of
the recombinant homologues allowed the immunological anal-
ysis detailed below. Sequence comparison of Ov20, Bm20, and
Av20 showed Ov20 and Av20 to be very similar, sharing three
N-linked glycosylation sites (NX[S/T]) and differing in only
nine amino acids (97% similarity) (Fig. 1). The codings for the
three glycosylation sites were identical except for the presence
of a serine residue at position 46 in Av20 instead of a threonine
as in Ov20. The Bm20 sequence was more divergent, with 26
amino acid differences from Ov20 (91% similarity), resulting in
the loss of all three glycosylation sites found in Ov20. However,
a new N-linked glycosylation site was located near the carboxy
terminus. It is unlikely that this site is used, as previous studies
FIG. 1. Alignment of the predicted amino acid sequences of the retinol
binding proteins Bm20, Ov20, and Av20. N-linked glycosylation sites are under-
lined, and areas of homology among the three recombinants are indicated (p).
The fragment representing Ov11 is highlighted.
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have shown no evidence that Bm20 is glycosylated (1a, 31).
The signal peptide sequence in Ov20 was conserved in the B.
malayi homologue. The mature Bm20 and Av20 proteins were
predicted to have molecular masses of 18.545 and 18.648 kDa,
respectively.
Serological responses in mice exposed to live parasites or
recombinant proteins. We have previously done extensive
analysis of immune responses in mice implanted with B. malayi
(1, 19, 20). This provided the necessary reagents for analysis of
serum reactivity to Bm20. Sera from mice implanted intraperi-
toneally with live adult B. malayi were assayed for reactivity to
parasite antigens Bm20 and whole B. malayi antigen, with
maltose binding protein (MBP) serving as a nonspecific con-
trol. While the BALB/c (H-2D), CBA (H-2K), BALB.k (H-2K)
mouse strains failed to show significant reactivity to Bm20,
C57BL/6 (H-2B) mice showed a high reactivity that was signif-
icantly different from background MBP (P , 0.01) (Fig. 2).
The results suggest a strong genetic restriction in response to
native Bm20 as had previously been observed for gp15/400.
The genetic restriction observed for gp15/400 was shown to
have both H-2 and non-H-2 components (1). To assess the role
of H-2 genes in the Bm20 responsiveness, BALB.b (H-2B) mice
were implanted with adult Brugia parasites and found to pro-
duce antibody to Bm20, suggesting that the response is at least
in part H-2 restricted (data not shown). When the Bm20-
reactive C57BL/6 serum was tested against all three recombi-
nant proteins, Av20 and Ov20 were not recognized despite
their sequence similarity to Bm20 (Fig. 3). This finding con-
firms previous specificity studies with Ov20 (4).
Sera from nonresponder mice (B10.D2, BALB.k, BALB/c,
and CBA) immunized with B. malayi parasite extract in
Freund’s complete adjuvant also failed to generate an anti-
body response to Bm20 (data not shown). In contrast, when
the studies were repeated with sera from mice immunized
with recombinant Bm20, all mouse strains tested (BALB/c,
C57BL/6, and B10.D2) exhibited a strong recognition of Bm20
and of Ov20 and Av20 (Fig. 4). Thus, the genetic restriction
and species specificity are overcome when recombinant, non-
native material is used.
Sera from mice immunized with Ov20 had a similar pattern
of recognition to the three recombinants; however, sera from
mice immunized with Ov11, a truncated version of Ov20 (Fig.
1) that has shown a high degree of specificity for onchocerciasis
sera (1), showed a different recognition pattern. The anti-Ov11
sera reacted significantly (P , 0.001) with Av20 and Ov20 in
comparison to normal serum controls but responded poorly to
Bm20 (Fig. 4).
Serological responses of human filarial sera. In B. malayi, a
15-kDa retinol and lipid binding polyprotein allergen (gp15/
400) which is immunodominant in elephantiasis has been char-
acterized (1, 14, 23). One of the objectives of this report was to
establish whether Bm20 was an immunogen in human filarial
infection. The reactivity of the three proteins with a panel of
human onchocerciasis and lymphatic filariasis sera was test-
ed. The lymphatic filariasis sera included sera from both B.
malayi- and W. bancrofti-infected individuals. B. malayi and
W. bancrofti are very closely related both phylogenetically and
pathologically. They both cause mosquito-borne diseases with
identical worm locations in the mammalian host and cause
very similar clinical symptoms. Ov20 and Av20 were recog-
nized strongly by onchocerciasis sera (P , 0.001) but not by
lymphatic filariasis sera, confirming previous studies on the
specificity of Ov20 (Fig. 5) (4). In contrast to Ov20 recognition
by onchocerciasis sera, Bm20 recognition by B. malayi sera was
only marginally significant despite the presence of the homo-
logue in the parasite. W. bancrofti sera showed no significant
reactivity to any of the three proteins. The slight differences in
reactivity between B. malayi and W. bancrofti is most likely due
to differences in geographic localization, as no significant re-
activity to Bm20 was observed in 28 B. malayi sera representing
four clinical categories from Sumatra, Indonesia (data not
shown). In all cases, the sera showed strong reactivity to whole
parasite extract.
DISCUSSION
Sequence comparison of the Ov20 homologues showed close
similarity between Ov20 and Av20 at both nucleotide and
amino acid levels, while the Bm20 sequence was more diver-
FIG. 2. Reactivity of BALB/c, BALB.k, C57BL/6, and CBA sera from mice
implanted intraperitoneally with live adult B. malayi. Plates were coated with
MBP, Bm20, and B. malayi extract (Bma). The y axis represents optical density
at 405 nm. Dotted bars, control unimplanted animals; solid bars, parasite-ex-
posed animals. Standard deviations represent two to four animals in control
groups and three to five animals in implanted group.
FIG. 3. Reactivity of sera from C57BL/6 mice implanted intraperitoneally
with B. malayi. Plates were coated with recombinant Bm20, Ov20, and Av20.
Standard deviations represent four to six animals in each group. C57cont and
C57imp, control and implanted C57BL/6 mouse sera; O.D., optical density.
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gent. Significantly, major differences were seen in the coding
for N-linked glycosylation sites. Three shared sites in Ov20 and
Av20 were replaced by a single new site in Bm20. The closer
relationship between Ov20 and Av20 compared to Bm20 is not
supported by phylogenetic analysis based on small-subunit
rRNA sequencing of O. volvulus, B. malayi, and A. viteae (2a),
suggesting that the changes may reflect important functional
differences between these molecules in the different organisms.
The secondary structure predicted for Ov20 is a short alpha
helix at the N terminus, corresponding to amino acids 30 to 46
of Ov20, followed by three longer alpha helices (15, 26). Two
copies of a degenerate repeat (Ile-Pro-Glu-Glu-tyr/Val-Lys-
Asn/Glu-Phe) seen in the region corresponding to the short
alpha helix of Ov20 also appears to be conserved in the B. ma-
layi and A. viteae homologues. The presence of a signal peptide
in both Ov20 and Bm20 suggests that the proteins are secreted,
but the localization of Bm20 has not been confirmed. Immu-
noprecipitation studies of the Av20 model have confirmed
secretion in all life cycle stages (21a).
In this study, four inbred strains of mice were exposed to
Bm20 in three contexts: by infection with live parasites, by
adjuvant-assisted immunization with the native molecule,
and by immunization with a recombinant molecule. Our results
show that the antibody responses to the native molecule are
controlled by factors within the H2 complex but that the re-
striction observed was overcome by immunization with the
E. coli-derived recombinant protein. We have previously ob-
served a high level of genetic restriction in the murine response
to the polyprotein allergen gp15/400 of B. malayi at both anti-
body and T-cell levels (1). These results suggest that features
of the native molecule interfere with its ability to be recognized
by host T cells.
We had originally proposed that glycosylation alters process-
ing or presentation of the antigen, but the absence of glyco-
sylation in native Bm20 suggests that the restricted response is
determined by other factors. It is intriguing to consider that
Bm20 and gp15/400, both retinol binding proteins, may bind
similar ligands in vivo, which may affect processing or recog-
nition of these molecules. Sera from mice immunized with
Ov20 and Bm20 E. coli recombinant molecules recognized all
three homologues (Ov20, Av20, and Bm20). In contrast, hu-
man onchocerciasis sera recognized only Ov20 and Av20, con-
FIG. 4. Reactivity of sera from mice immunized with recombinant Bm20, Ov20, and Ov11. Plates were coated with recombinant Bm20, Av20, and Ov20. Standard
deviations represent four to six animals in each group. C57aBm20, BALBaBm20, and B10aBm20, sera from C57BL/6, BALB/c, and B10.D2 mice immunized with
Bm20; aOv20, sera from mice immunized with Ov20; aOv11, sera from mice immunized with Ov11; BALBnms and B10nms, normal serum controls from BALB/c and
B10.D2 mice; O. D., optical density.
FIG. 5. Reactivity of human filarial (W. bancrofti and B. malayi) and onchocerciasis sera to the recombinant proteins Bm20, Ov20, and Av20. Standard deviations
represent 35 samples in the onchocerciasis (Oncho) serum group, 18 samples in the Brugia serum group, 22 samples in the Wuchereria (Wuch) serum group and 7 to
8 samples in the control (uninfected) group. O. D., optical density.
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sistent with the close sequence relationship between these two
proteins. The difference in reactivity to Bm20 observed be-
tween mice immunized with Ov20 and its specific fragment
Ov20/11 suggests that the central portion of the molecule de-
termines species specificity (Fig. 4). The close relationship
between Ov20 and Av20 suggests that Av20 could be used in an
A. viteae infection model in mice to investigate the biological
functions of Ov20, which have up to now been hampered by
the inability to maintain O. volvulus in a laboratory setting.
The reactivity patterns of Bm20, however, were distinct from
those of the other molecules, as sera from patients infected
with B. malayi failed to recognize it, suggesting that antigenic
epitopes are not exposed to the immune system during the
natural course of the infection in humans. However, the ability
of C57BL/6 to respond strongly to Bm20 during live infection
suggests that antigenic epitopes are in fact accessible and that
alternative explanations for the lack of reactivity in the human
population may be needed. It is possible that active suppres-
sion of Bm20 or competition with more dominant antigens or
rapid degradation contributes to this nonresponsiveness ob-
served in the human host. Ov20 is immunodominant in O.
volvulus, but its homologue in B. malayi is apparently not. It is
unlikely that sequence differences alone could explain the non-
responsiveness of Brugia sera to Bm20.
The possible role of glycosylation in immunomodulation is
an interesting area of future study. Carbohydrates may be
important in determining which epitopes are processed or pre-
sented to the immune system (33), and the differential glyco-
sylation observed in the three molecules may contribute to
the differential reactivity observed. Furthermore, glycosylation
may determine extracellular stability, as one of the key func-
tions of glycosylation is to protect proteins from proteolytic
degradation; i.e., Bm20 may be secreted but more rapidly de-
graded. Yet another possible explanation is the presence of a
sheath in B. malayi microfilariae which could impede secretion
of the protein into host tissue and thereby reduce tissue Bm20
levels significantly. It is intriguing to consider the possibility
that gp15/400, a protein which has a profile of retinol binding
similar to those of Ov20 (14) and Bm20 (12a) and is both
immunodominant and glycosylated, may play the role of Ov20
in Brugia infection.
The function of Ov20 (and its homologues) in vivo remains
to be established, but there are a number of reasons why this
retinol binding molecule may play a critical role in the immu-
nity and pathogenesis of filarial nematode infections. The role
of retinoids other than in vision is an area considerable interest
(2, 9, 10, 32). Filariae concentrate and store retinol in excess of
host tissue (28, 30). Retinoids have been shown to be impor-
tant in development of a type 2 immune response, with vitamin
A-deficient mice displaying a tendency toward a type 1 re-
sponse, an effect occurring at the level of antigen-presenting
cells as well as at the T-cell level (6, 8). Retinoids influence
collagen gene expression, and collagen formation plays a major
role in the pathogenesis of onchocerciasis (7). It may be rele-
vant here that a 19-kDa retinol binding protein from O. vol-
vulus is reported to bind ivermectin, the drug currently used for
control of the disease (18, 27, 28). The fact that Ov20 appears
to have no counterpart in the mammalian host is encouraging
in that it could provide a novel therapeutic target for onchocer-
ciasis therapy.
It is crucial that further studies be done to establish the
functional significance of this retinol binding protein, and it is
our hope that the cloning of its homologues (Bm20 and Av20)
and the availability of two different model systems will help
achieve this objective. The greater similarity in both immune
reactivity and glycosylation between Av20 and Ov20 suggests
that Av20 would be the better model antigen. In addition,
important differences in the reactivity patterns of the O. vol-
vulus and B. malayi homologues suggest that differences in the
immune recognition of this molecule in the two parasite sys-
tems may be due to differences in glycosylation.
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